Assessment of oral antithrombotic therapy by platelet function testing. - Wikidata - wikimedia - TriplyDB

Assessment of oral antithrombotic therapy by platelet function testing.

Assessment of oral antithrombotic therapy by platelet function testing.

http://www.wikidata.org/entity/Q37902507

about

Biochemical markers of aging for longitudinal studies in humans.State of the art in platelet function testing.Relationship between ADP-induced platelet-fibrin clot strength and anti-platelet responsiveness in ticagrelor treated ACS patients Management of bleeding disorders in the elderly.

P2860

Q36449881-1328A441-71E0-465C-891D-B3D67E943C9A Q36802971-35C2719F-D1FD-4E4D-8E28-DD717390F2B2 Q37039218-C3AA261C-D3A1-46F0-97DF-E6CD5B685C4E Q38005181-29745AF0-2AB1-40D5-ABD3-BDFE11949CD4

P2860

Assessment of oral antithrombotic therapy by platelet function testing.

http://www.wikidata.org/entity/Q37902507

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 19 July 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Assessment of oral antithrombotic therapy by platelet function testing.

@en

Assessment of oral antithrombotic therapy by platelet function testing.

@nl

type

label

Assessment of oral antithrombotic therapy by platelet function testing.

@en

Assessment of oral antithrombotic therapy by platelet function testing.

@nl

prefLabel

Assessment of oral antithrombotic therapy by platelet function testing.

@en

Assessment of oral antithrombotic therapy by platelet function testing.

@nl

P1433

Q37902507-A3CD04F8-451E-4077-BE95-1C5BC5BCF1E4

P1476

Q37902507-66800969-1056-4D99-AC36-B2D415F3CAA1

P2093

Q37902507-0A0E312B-9F28-4DE8-9590-CBEDB8CE4E42

Q37902507-ACFFD0EF-05F2-4AD1-8728-227B7F65AC5D

P2860

Q37902507-04427AF6-7F1B-4DCD-9FEC-BF435DE124EC

Q37902507-10F1F903-C578-4152-9BEF-2B0D533BC116

Q37902507-151CAE31-2843-478A-9B09-89FACEEABB0A

Q37902507-220C438F-CFCF-479E-AC8E-F35B958FC7B8

Q37902507-22AC8D88-1A25-4C57-955C-F2364FA9A10A

Q37902507-22E27250-02AC-497F-988E-3929E1542BCB

Q37902507-22E9956E-9051-4FE9-AE8A-56B3E6CA9FC6

Q37902507-27774C44-FA82-43BE-8ADA-5DE45653FF71

Q37902507-2CB001BA-19D0-462F-89B4-DC0F4331FFB8

Q37902507-2F8C391F-ECFF-4D9C-91D5-AA12175E02F9

P304

Q37902507-52BCA5D8-67C3-4C80-9F4D-19F22E36D596

P31

Q37902507-CE731407-40F1-4735-8FDE-40A953C15664

P356

Q37902507-07122FAC-5AB0-44A2-A4AE-8E57B320B493

P407

Q37902507-25083864-2327-42A7-AD3C-8D25A9E93D09

P433

Q37902507-425E6994-B3DC-450E-8F2B-EB29D7D17493

P478

Q37902507-4E4688D1-A27B-4608-A5D5-A5E07A0280EB

P577

Q37902507-87A42B2D-6D93-4311-8D5E-B6647F219F09

P698

Q37902507-8A35B2DE-C7EA-477C-8EF8-6D5519DBB898

P356

NRCARDIO.2011.107

P1433

Nature Reviews Cardiology

P1476

Assessment of oral antithrombotic therapy by platelet function testing.

@en

P2093

Paul A Gurbel

http://www.w3.org/2001/XMLSchema#string

Udaya S Tantry

http://www.w3.org/2001/XMLSchema#string

P2860

Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

Meta-analysis of trials comparing oral anticoagulation and aspirin versus dual antiplatelet therapy after coronary stenting. Clues for the management of patients with an indication for long-term anticoagulation undergoing coronary stenting

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

Platelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING Study

Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity

Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study

Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting

Dabigatran versus warfarin in patients with atrial fibrillation

Dabigatran etexilate--a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity

P304

572-579

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRCARDIO.2011.107

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2011-07-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21769112

http://www.w3.org/2001/XMLSchema#string